Oruka Therapeutics announced that it will receive $275 million in a round of funding on April 3, 2024. The transaction included participation from syndicate of healthcare investors.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.54 USD | +3.21% | -4.84% | +104.31% |
Apr. 25 | ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
+104.31% | 49.74M | |
-2.79% | 102B | |
+1.85% | 96.29B | |
+2.01% | 22.18B | |
-15.34% | 21.2B | |
-8.82% | 18.31B | |
-38.74% | 17.38B | |
-13.60% | 16.36B | |
+6.21% | 13.97B | |
+34.26% | 12.17B |
- Stock Market
- Equities
- ABIO Stock
- News ARCA biopharma, Inc.
- Oruka Therapeutics announced that it expects to receive $275 million in funding